RECALL DATABASE

Duloxetine Recall: Ajanta Pharma USA DR Capsules 30 mg

Announced 2026-07-29 · FDA

Asclemed USA Inc. is recalling 50 bottles of Duloxetine DR Capsules, 30 mg, 30-count bottles, distributed nationwide in the US (Lot # 050725G-30 and 050725F-30; Exp 06/30/2026). The recall is due to CGMP deviations and the presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the FDA acceptable intake limit. No corrective action information is provided.

BrandAsclemed USA Inc.
ProductDuloxetine DR Capsules, 30 mg, 30 count bottles, Rx, Relabeled by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC 76420-634-30, Marketed by: Ajanta Pharma USA Inc.
ReasonCGMP Deviations; presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the FDA acceptable intake limit.
Severitymoderate
Units affected18
DistributionUS Nationwide.
AgencyFDA

WHAT YOU SHOULD DO

  1. If you have any recalled lots (Lot # 050725G-30 or 050725F-30) with expiry 06/30/2026, stop taking the product and contact your pharmacist or healthcare provider.
  2. Do not use any more of the recalled bottles; follow disposal or return instructions from your pharmacist or the recall notice.
  3. Keep the product packaging and lot number information until you have received further instructions from your healthcare provider or the recall notice.

How to identify the recalled item

Lot / date codesLot # 050725G-30 & 050725F-30, Exp Date: 06/30/2026
Lot / date codesLot: 070126X1, Exp. 12/31/2027.

These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.

Other duloxetine recalls

See every duloxetine recall →

This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.